MX2017014418A - Composiciones hemostaticas. - Google Patents
Composiciones hemostaticas.Info
- Publication number
- MX2017014418A MX2017014418A MX2017014418A MX2017014418A MX2017014418A MX 2017014418 A MX2017014418 A MX 2017014418A MX 2017014418 A MX2017014418 A MX 2017014418A MX 2017014418 A MX2017014418 A MX 2017014418A MX 2017014418 A MX2017014418 A MX 2017014418A
- Authority
- MX
- Mexico
- Prior art keywords
- biocompatible
- compositions
- haemostatic
- biocompatible liquid
- haemostatic compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Polymers & Plastics (AREA)
Abstract
Una composición hemostática estéril, lista para usar y fluida que comprende un agente hemostático soluble que comprende múltiples portadores y múltiples péptidos de unión a fibrinógeno inmovilizados en el portador; un líquido biocompatible; y partículas de un polisacárido reticulado biocompatible adecuado para su uso en hemostasia que son insolubles en el líquido biocompatible. Dichas composiciones se pueden utilizar para el control de sangrado, especialmente en procedimientos quirúrgicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1508024.5A GB201508024D0 (en) | 2015-05-11 | 2015-05-11 | Haemostatic compositions |
PCT/GB2016/051346 WO2016181137A1 (en) | 2015-05-11 | 2016-05-11 | Haemostatic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017014418A true MX2017014418A (es) | 2018-03-02 |
Family
ID=53489436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017014418A MX2017014418A (es) | 2015-05-11 | 2016-05-11 | Composiciones hemostaticas. |
Country Status (15)
Country | Link |
---|---|
US (1) | US11246958B2 (es) |
EP (1) | EP3294353B1 (es) |
JP (1) | JP6877360B2 (es) |
KR (1) | KR102645212B1 (es) |
CN (1) | CN107592814B (es) |
AU (1) | AU2016261108B2 (es) |
BR (1) | BR112017024162A2 (es) |
CA (1) | CA2983798A1 (es) |
GB (1) | GB201508024D0 (es) |
HR (1) | HRP20240065T1 (es) |
IL (1) | IL255579A (es) |
MX (1) | MX2017014418A (es) |
PH (1) | PH12017501946A1 (es) |
RU (1) | RU2744694C2 (es) |
WO (1) | WO2016181137A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE544460C2 (en) * | 2019-12-18 | 2022-06-07 | Amferia Ab | Improved wound care device |
KR20230099838A (ko) | 2021-12-28 | 2023-07-05 | 인천대학교 산학협력단 | 가교 활성 지혈제 및 이의 용도 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE426902B (sv) * | 1980-05-23 | 1983-02-21 | Einar Sjolander | Etbart holje samt sett for dess framstellning |
SE9101853D0 (sv) * | 1991-06-17 | 1991-06-17 | Jonas Wadstroem | Improved tissue ashesive |
US5783663A (en) * | 1998-01-23 | 1998-07-21 | Bayer Corporation | Peptide ligands for affinity purification of fibrinogen |
MXPA01002898A (es) | 1998-09-21 | 2002-06-04 | Genetics Inst | Metodos de modulacion descendente de la respuesta inmune a proteinas terapeuticas. |
FR2813080B1 (fr) * | 2000-08-17 | 2002-11-29 | Stago Diagnostica | Peptides anti-heparine |
CA2447383A1 (en) * | 2001-06-29 | 2003-01-09 | Biovitrum Ab | Process for bulk autoclaving |
CN101675991A (zh) * | 2001-12-21 | 2010-03-24 | 诺和诺德医疗保健公司 | 因子ⅶ多肽的液体组合物 |
US20040101546A1 (en) | 2002-11-26 | 2004-05-27 | Gorman Anne Jessica | Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents |
CA2530032C (en) | 2003-06-16 | 2015-11-24 | Loma Linda University Medical Center | Deployable multifunctional hemostatic agent |
GB0323378D0 (en) * | 2003-10-07 | 2003-11-05 | Univ Leicester | Therapeutic agent |
US7431915B2 (en) | 2003-10-31 | 2008-10-07 | The Regents Of The University Of California | Peptides whose uptake by cells is controllable |
US7842667B2 (en) * | 2003-12-22 | 2010-11-30 | Regentis Biomaterials Ltd. | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
EP2289567A3 (en) * | 2003-12-22 | 2011-06-22 | Regentis Biomaterials Ltd. | Matrix comprising naturally-occurring crosslinked protein backbone |
US8124120B2 (en) * | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
CA2571981C (en) | 2004-07-09 | 2014-12-30 | Ferrosan A/S | Haemostatic composition comprising hyaluronic acid |
JP2008507362A (ja) | 2004-07-22 | 2008-03-13 | ヘモ ナノサイエンス リミテッド ライアビリティ カンパニー | 過剰な出血を処置するための組成物および方法 |
GB0516091D0 (en) * | 2005-08-04 | 2005-09-14 | Haemostatix Ltd | Therapeutic agent |
GB0623607D0 (en) | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
JP6084770B2 (ja) * | 2008-06-26 | 2017-02-22 | プロリンクス エルエルシー | 制御された薬剤放出速度を有するプロドラッグ及び薬剤−高分子のコンジュゲート |
US20100021527A1 (en) | 2008-07-25 | 2010-01-28 | Chunlin Yang | Collagen-related peptides and uses thereof and hemostatic foam substrates |
WO2011006069A1 (en) * | 2009-07-09 | 2011-01-13 | Georgia Tech Research Corporation | Peptides for binding fibrinogen and fibrin |
US20110171310A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
GB201101740D0 (en) * | 2011-02-01 | 2011-03-16 | Haemostatix Ltd | Therapeutic agents with improved fibrinogen binding |
CN103443117B (zh) * | 2011-04-29 | 2017-05-17 | 凯希特许有限公司 | 用于治疗因子在伤口环境中的结合的适体改性的聚合材料 |
MX356185B (es) * | 2011-10-11 | 2018-05-17 | Baxter Int | Composiciones hemostaticas. |
WO2013060769A2 (en) * | 2011-10-27 | 2013-05-02 | Baxter International Inc. | Hemostatic compositions |
MX2014007500A (es) * | 2011-12-20 | 2014-07-28 | Pfizer | Procesos mejorados para preparar conjugados y enlazadores de peptido. |
GB201201751D0 (en) * | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
JP6322192B2 (ja) | 2013-07-08 | 2018-05-09 | デンカ株式会社 | コアシェル型架橋ヒアルロン酸ゲル粒子、その製造方法及び医用材料 |
GB201400292D0 (en) * | 2014-01-08 | 2014-02-26 | Haemostatix Ltd | Peptide dendrimers and agents |
CN104398287A (zh) * | 2014-11-27 | 2015-03-11 | 张汉桥 | 医用微创伤口止血固定带 |
-
2015
- 2015-05-11 GB GBGB1508024.5A patent/GB201508024D0/en not_active Ceased
-
2016
- 2016-05-11 KR KR1020177034020A patent/KR102645212B1/ko active IP Right Grant
- 2016-05-11 AU AU2016261108A patent/AU2016261108B2/en active Active
- 2016-05-11 BR BR112017024162A patent/BR112017024162A2/pt not_active Application Discontinuation
- 2016-05-11 JP JP2017558001A patent/JP6877360B2/ja active Active
- 2016-05-11 MX MX2017014418A patent/MX2017014418A/es unknown
- 2016-05-11 HR HRP20240065TT patent/HRP20240065T1/hr unknown
- 2016-05-11 US US15/572,915 patent/US11246958B2/en active Active
- 2016-05-11 CA CA2983798A patent/CA2983798A1/en active Pending
- 2016-05-11 WO PCT/GB2016/051346 patent/WO2016181137A1/en active Application Filing
- 2016-05-11 CN CN201680027393.2A patent/CN107592814B/zh active Active
- 2016-05-11 RU RU2017139789A patent/RU2744694C2/ru active
- 2016-05-11 EP EP16723460.8A patent/EP3294353B1/en active Active
-
2017
- 2017-10-25 PH PH12017501946A patent/PH12017501946A1/en unknown
- 2017-11-09 IL IL255579A patent/IL255579A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20180154038A1 (en) | 2018-06-07 |
RU2017139789A3 (es) | 2019-07-29 |
KR20180006390A (ko) | 2018-01-17 |
CA2983798A1 (en) | 2016-11-17 |
PH12017501946A1 (en) | 2018-03-19 |
IL255579A (en) | 2018-01-31 |
KR102645212B1 (ko) | 2024-03-07 |
RU2744694C2 (ru) | 2021-03-15 |
RU2017139789A (ru) | 2019-06-11 |
BR112017024162A2 (pt) | 2018-07-17 |
AU2016261108A1 (en) | 2017-11-16 |
EP3294353A1 (en) | 2018-03-21 |
CN107592814A (zh) | 2018-01-16 |
CN107592814B (zh) | 2021-12-03 |
JP6877360B2 (ja) | 2021-05-26 |
HRP20240065T1 (hr) | 2024-03-29 |
EP3294353B1 (en) | 2023-10-25 |
JP2018515216A (ja) | 2018-06-14 |
US11246958B2 (en) | 2022-02-15 |
WO2016181137A1 (en) | 2016-11-17 |
GB201508024D0 (en) | 2015-06-24 |
AU2016261108B2 (en) | 2020-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014004475A (es) | Composición hemostatica. | |
MX356185B (es) | Composiciones hemostaticas. | |
PH12017501342A1 (en) | Glycan therapeutics and related methods thereof | |
MX355924B (es) | Composicion hemostatica. | |
EA030970B8 (ru) | Композиция для восстановления функции тонкого кишечника, способы ее приготовления и применения | |
MX2012007922A (es) | Sellante de fibrina en polvo seco. | |
WO2014058804A3 (en) | Micronized compositions composed of bone grafts and methods of making and using the same | |
CO2017002335A2 (es) | Una composición de adhesivo termofusible elástico y un material compuesto elástico elaborado con esta | |
GB2520897A (en) | Compositions and methods for treating cutaneous scarring | |
MX363991B (es) | Aposito antimicrobiano multifuncion para la cobertura de un cateter. | |
MX2015010327A (es) | Adhesivos antimicrobianos que tienen propiedades mejoradas . | |
MX2020011866A (es) | Metodo para preparar una composicion hemostatica. | |
MX359402B (es) | Composiciones no acuosas para hemostasia osea, y metodos para su uso y fabricacion. | |
WO2018212792A3 (en) | BIOPOLYMER COMPOSITIONS, SCAFFOLDING AND DEVICES | |
MX2019006291A (es) | Composiciones de lactato de calcio y metodos de uso. | |
MY175309A (en) | Pharmaceutical composition useful for adhesion prevention or hemostasis | |
PH12021550303A1 (en) | Superabsorbent materials and methods of making the same | |
MX2015017273A (es) | Composiciones que comprenden acido hialuronico reticulado y ciclodextrina. | |
NZ631536A (en) | Treatment of diseases involving mucin | |
AR105098A1 (es) | Soporte polimérico adhesivo hemostático altamente eficaz | |
TR201713929A2 (tr) | Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari | |
MX2017011299A (es) | Material para envasado que comprende composicion antimicrobiana. | |
MX2015013040A (es) | Producto y proceso para normalización de la viscosidad del moco. | |
PH12017501946A1 (en) | Haemostatic compositions | |
EP3718578A4 (en) | COMPOSITION FOR HAEMOSTASIS AND CONTAINER INCLUDING IT |